| Literature DB >> 25574643 |
Antti P Launonen1, Vesa Lepola, Tapio Flinkkilä, Minna Laitinen, Mika Paavola, Antti Malmivaara.
Abstract
BACKGROUND ANDEntities:
Mesh:
Year: 2015 PMID: 25574643 PMCID: PMC4443467 DOI: 10.3109/17453674.2014.999299
Source DB: PubMed Journal: Acta Orthop ISSN: 1745-3674 Impact factor: 3.717
PICOS criteria for the trials included
| Patients: | Age 60 years or older with a 2-, 3-, or 4-part proximal humerus fracture due to recent trauma |
| Intervention: | Any operative treatment (at least 20 patients in each treatment group) |
| Control: | Any treatment (at least 20 patients in each treatment group) |
| Outcome: | Any functional or disability score and/or any quality-of-life score after a minimum follow-up of 1 year |
| Study setting: | Randomized, controlled trial or controlled clinical trial |
Figure 1.Flow chart of publications investigated, from search for abstracts to final analysis.
Study designs
| A | B | C | D | E | F | G | H | I | J | K | L |
|---|---|---|---|---|---|---|---|---|---|---|---|
|
| Sweden | RCT | 3(-4) | Tension band (20) | Nonoperative (20) | 12 | 40/38 | 73 | 75 | 2 | |
|
| Austria | RCT | 4 | 11-C | Hemiarthroplasty | Hemiarthroplasty | 12 | 40/35 | 74 | 73 | 5 |
| (Epoca (20)) | (HAS (20)) | ||||||||||
|
| Norway | RCT | 3-4 | 11-B2, 11-C2 | Plating | Nonoperative (25) | 12 | 50/48 | 72 | 73 | 2 |
|
| Sweden | RCT | 4 | Hemiarthroplasty | Nonoperative (28) | 24 | 55/49 | 76 | 78 | 6 | |
| (Global FX (27)) | |||||||||||
|
| Sweden | RCT | 3 | Plating (Philos (30)) | Nonoperative (30) | 24 | 60/53 | 73 | 75 | 7 | |
|
| Germany | RCT | 3-4 | Plating (humeral | Plating (Philos (31)) | 12 | 56/48 | 76 | 72 | 8 | |
| suture plate (25)) | |||||||||||
|
| Norway | RCT | 3-4 | 11-B2, 11-C2 | Plating | Nonoperative (25) | 12 | 50/48 | 72 | 73 | 2 |
|
| Netherlands | RCT | 4 | Hemiarthroplasty | Nonoperative (25) | 12 | 50/47 | 76 | 80 | 3 | |
| (Global FX (25)) | |||||||||||
|
| Italy | CCT | 3-4 | MIROS pinning (31) | Traditional pinning (27) | 24 | 58/52 | 78 | 81 | 6 |
AAuthor
BCountry
CDesign
DNeer
EAO-OTA
FIntervention (n at baseline)
GControl (n at baseline)
HFollow-up, months
INo. of patients at baseline/follow-up
JMean age (intervention group)
KMean age (control group)
LDrop-out, n
Nonspecific LCT AO-type locking plate.
Both publications are from the same population.
Functional results of the trial. Values are mean (SD) unless otherwise stated
| Primary outcome measure | Secondary outcome measure | Adjacent outcome measure | |||||||
|---|---|---|---|---|---|---|---|---|---|
| Author | Intervention | Control | p-value | Intervention | Control | p-value | Intervention | Control | p-value |
|
| CS: 60 (19) | 65 (15) | > 0.05 | ||||||
|
| ICS: 70 (38–102) | 46 (15–80) | 0.001 | CS: 52 (20–80) | 33 (8–68) | na | |||
|
| CD: 35 (28–43) | 33 (26–40) | 0.6 | ASES: 15 (12–18) | 16 (13–18) | 0.7 | |||
|
| EQ: 0.81 (0.12) | 0.65 (0.27) | 0.02 | CS: 48 (16) | 50 (21) | 0.8 | DASH: 30 (18) | 37 (21) | 0.3 |
|
| CS: 61 (19) | 58 (23) | 0.6 | DASH: 26 (25) | 36 (27) | 0.2 | EQ: 0.70 (0.34) | 0.59 (0.35) | 0.3 |
|
| SST: 8 (3) | 10 (2) | 0.3 | DASH: 18 (16) | 16 (12) | 1.0 | CS: 73 | 81 | > 0.05 |
|
| 15D: 0.84 (0.11) | 0.82 (0.08) | 0.4 | ||||||
|
| CS: 64 (16) | 60 (18) | 0.4 | SST: 25 (8–100) | 23 (0–92) | 0.6 | VAS12: 23 (1–65) | 25 (1–93) | 0.7 |
|
| CS: 60 | CS: 52 | 0.02 | SSV: 90 | 73 | 0.02 | |||
CS = Constant Score;
ICS = Individual Constant Score determined by comparing the operated shoulder to the patient’s unaffected shoulder in percent;
CD = Constant Score difference at 12 months, and to reduce the influence of age, the difference between the scores for the injured and
uninjured shoulders was used;
ASES = American Shoulder and Elbow Surgeons Shoulder Score
EQ = Euroqol-5D
DASH = Disabilities of the Arm, Shoulder, and Hand
SST = Simple Shoulder Test
SSV = Subjective Shoulder Value
VAS12 = Visual Analogue Scale at 12 months, mean (range)
Both publications are from the same population.
Threshold values
Range